5-amino-1mq nnmt inhibitor study Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target 5-Amino-1MQ Research Compound 10mg |

The recommended 5-amino-1MQ dosage ranges from 50-100mg daily via subcutaneous injection

The peptide belongs to a class of compounds known as growth hormone fragments or lipolytic peptides

This product is in its lyophilized powder form (freeze dried)

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

For the beta diversity analyses, an analysis of similarities (ANOSIM) was performed on each of the distance/dissimilarity matrices to establish whether observed clustering by treatment group was statistically significant